Obermatt
See Similar Stocks →

Integral Diagnostics

ASX:IDX · AU000000IDX2
Health Care Providers & ServicesMedium

360

45
EV / EBIT64
Price / Owner Earnings93
Owner Earnings Yield1
Dividend Yield89
Price/Sales72
EV / Gross Profit38
Price/Book66
Return on Capital52
Cash Return on Capital41
Return on Equity52
EBIT Margin68
Gross Profitability23
Cash Conversion89
Accruals41
Owner Earnings Margin37
Sales growth91
Profit Growth30
Long-Term EPS Growth76
Reinvestment32
Price momentum45
Debt load13
Refinancing12
Debt Payback1
Liquidity26
Analyst ratings83
Opinion Changes50
Price Target Upside81
Market mood57
Value Creation8/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Integral Diagnostics clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryAustralia
IndustryHealth Care Providers & Services
SizeMedium
TypePublic Company
ExchangeASX
Founded2008
Employees241
Websiteintegraldiagnostics.com.au
ISINAU000000IDX2
Last UpdateApr 2, 2026
Indices
ASX 300 (Australia)
Themes
Health DiagnosticsBiotechnologyHealth CareMedical

Description

Integral Diagnostics Limited, a healthcare services company, engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied health professionals and their patients in Australia and New Zealand. Busi…

Analysis

Middle-of-the-road

Integral Diagnostics Limited sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

Valuation data is not available for this company.

Growth is solid; the safety picture is stretched. The company scores 8/20 on our value-creation score: creating some value.

Flags to be aware of: The financial cushion is thinner than comfortable. A large part of the company's book value is the price paid for past acquisitions. As always: this describes the company's numbers; it is not a recommendation.

360° rank · history

1007550250
58
2023202420252026

All-time high

71

Jan 2025

All-time low

17

Jan 2024

Average rank

49

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
72
63
79
57
Price/Earnings
54
44
54
47
Price/Book
66
40
71
45
Dividend Yield
89
74
74
68
Value (overall)
75
55
53
55

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Integral Diagnostics with its peers
Sonic
ASX:SHL
36
CountryAustralia
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →
Ramsay Health Care
ASX:RHC
15
CountryAustralia
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →
Fukuda Denshi
TYO:6960
73
CountryJapan
IndustryHealth Care Equipment & Supplies
SizeMedium
Full Stock Analysis →
Prenetics Global
NMQ:PRE
52
CountryHong Kong SAR China
IndustryHealth Care Providers & Services
SizeSmall
Full Stock Analysis →
Nanosonics
ASX:NAN
71
CountryAustralia
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Apex Biotechnology
TAI:1733
72
CountryTaiwan
IndustryHealth Care Equipment & Supplies
SizeX-Small
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →